Entry details

Wrensch et al. (2009) "Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility." Nat. Genet. 41(8):905-908 (PubMed)

Cited by (in linked databases)

  1. CDKN2B, cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) GenAge: Human Ageing-Associated Genes